Events 2007
Events 2007
[ November 2007 ]56th American Society of Tropical Medicine and Hygiene
(ASTMH) - Philadelphia, USA / DNDi's Symposium on ACT
Sanofi-aventis and DNDi held a symposium on the implementation of a new artemisinin
combination therapy (ACT) in African endemic countries. Over 120 attendees from NGOs,
academia, and the pharmaceutical sector heard presentations by FACT project partners on ASAQ and ASMQ. In addition, DNDi also presented the ethical considerations of malaria field studies, and screening of natural products against infectious disease pathogens.
[ September 2007 ]
Scientific Symposium on Visceral Leishmaniasis (VL) - London
DNDi and the Leishmaniasis East Africa Platform (LEAP) organised a scientific symposium on
visceral leishmaniasis (VL): “A step together in the right direction” at the centenary meeting
of the Royal Society of Tropical Medicine and Hygiene (RSTMH), in London. More than
120 scientists attended the meeting.
Click here to check the program
Scientific Symposium on Visceral Leishmaniasis (VL) - London
DNDi and the Leishmaniasis East Africa Platform (LEAP) organised a scientific symposium on
visceral leishmaniasis (VL): “A step together in the right direction” at the centenary meeting
of the Royal Society of Tropical Medicine and Hygiene (RSTMH), in London. More than
120 scientists attended the meeting.
Click here to check the program
[ June 2007 ]
The Pan-Asian Network for Neglected Diseases (PAN4ND)
Annual Meeting - Shanghai
The PAN4ND Annual Meeting was held at Shanghai Institute Materia Medica,
4th-6th June 2007, and included three sessions: The Annual Meeting of the
Pan-Asian Screening Network; the Natural Product Working Group, and the
Natural Product Symposium.
Click here to read more
The Pan-Asian Network for Neglected Diseases (PAN4ND)
Annual Meeting - Shanghai
The PAN4ND Annual Meeting was held at Shanghai Institute Materia Medica,
4th-6th June 2007, and included three sessions: The Annual Meeting of the
Pan-Asian Screening Network; the Natural Product Working Group, and the
Natural Product Symposium.
Click here to read more
[ May 2007 ]
5th European Congress on Tropical Medicine & International Health
(ECTMIH) - Amsterdam
DNDi, in 2 presentations, discussed how Product Development Partnerships
could deliver innovative treatments to patients, and the sanofi-aventis/DNDi Partnership
against malaria, at the 5th ECTMIH from 24 to 28 May in Amsterdam.
Click here to read the program
5th European Congress on Tropical Medicine & International Health
(ECTMIH) - Amsterdam
DNDi, in 2 presentations, discussed how Product Development Partnerships
could deliver innovative treatments to patients, and the sanofi-aventis/DNDi Partnership
against malaria, at the 5th ECTMIH from 24 to 28 May in Amsterdam.
Click here to read the program
[ March 2007 ]
ASAQ Launch
Sanofi-aventis and DNDi launched ASAQ, the new fixed-dose combination of
artesunate (AS) and amodiaquine (AQ), which is now available in 21 countries
throughout sub-Saharan Africa (June 08). ASAQ, the first drug developed by DNDi,
is an innovative product to treat malaria that is adapted to the needs of patients of all ages,
simple to use, accessible as a non patented drug, and available at an affordable price.
ASAQ Launch
Sanofi-aventis and DNDi launched ASAQ, the new fixed-dose combination of
artesunate (AS) and amodiaquine (AQ), which is now available in 21 countries
throughout sub-Saharan Africa (June 08). ASAQ, the first drug developed by DNDi,
is an innovative product to treat malaria that is adapted to the needs of patients of all ages,
simple to use, accessible as a non patented drug, and available at an affordable price.
Except where otherwise noted, content on this site is licensed under
a Creative Commons Attribution-Noncommercial-Share Alike 2.5 Switzerland License